SCHEMBL6635754

SCHEMBL6635754

Cn1ccc(S(=O)(=O)N(c2ccc(OC(=O)N3CCN(c4ccccn4)CC3)c(Cl)c2)[C@@](C)(C(=O)O)C(=O)[C@H]2NC(C)(C)CS2)n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.37
SMN1; SMN2 Q16637 7/20 0.37
KDM4E B2RXH2 10/20 0.34
ALDH1A1 P00352 8/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 6/20 0.33
MAPK1 P28482 5/20 0.33
TSHR P16473 5/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
ADRB2 P07550 2/20 0.32
PKM P14618 1/20 0.32
CYP3A4 P08684 1/20 0.32
HTT P42858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636303 0.93 KDM4E (0.34) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL3853401 0.80 KDM4E (0.35) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL3849517 0.78 KDM4E (0.34) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL3851899 0.71 P2RX7 (0.38) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL4413794 0.71 ALDH1A1 (0.36) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL6632031 0.71 BCHE (0.37) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL3851010 0.69 ADRB2 (0.37) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL6636006 0.69 OXTR (0.32) ALDH1A1KMT2APKM
SCHEMBL6461059 0.69 ADRB2 (0.35) LMNAKDM4EALDH1A1MEN1KMT2A
SCHEMBL6632870 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-B1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2004-05-19 EP claimed